
Spectrum Pharmaceuticals SPPI
Spectrum Pharmaceuticals P/CF | SPPI
P/CF Jährlich Spectrum Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.27 | -0.881 | -3.51 | -2.35 | -17.9 | -47.1 | -11.5 | 43.5 | -111 | -243 | 9.16 | 17.2 | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 43.5 | -243 | -30.7 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Brickell Biotech
BBI
|
-2.62 | - | -5.38 % | $ 6.06 M | ||
|
Applied Therapeutics
APLT
|
-9.8 | - | - | $ 8.42 M | ||
|
ESSA Pharma
EPIX
|
-3.24 | - | - | $ 8.86 M | ||
|
Generation Bio Co.
GBIO
|
-3.39 | - | - | $ 344 M | ||
|
Clearside Biomedical
CLSD
|
-5.59 | - | - | $ 25.3 M | ||
|
Merus N.V.
MRUS
|
-16 | - | - | $ 5.78 B | ||
|
RAPT Therapeutics
RAPT
|
-0.568 | - | - | $ 2.36 B | ||
|
Annexon
ANNX
|
-4.13 | $ 3.11 | -8.94 % | $ 482 M | ||
|
Acasti Pharma
ACST
|
-2.73 | - | 4.01 % | $ 150 M | ||
|
Aptose Biosciences
APTO
|
-0.0645 | - | -45.71 % | $ 1.2 M | ||
|
Galapagos NV
GLPG
|
-7.4 | - | - | $ 1.83 B | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
-0.0137 | - | -4.36 % | $ 27 M | ||
|
Avenue Therapeutics
ATXI
|
-0.0603 | - | -52.27 % | $ 4.45 M | ||
|
Galmed Pharmaceuticals Ltd.
GLMD
|
-0.505 | $ 4.63 | 21.05 % | $ 20 M | ||
|
Achieve Life Sciences
ACHV
|
-2.56 | $ 6.78 | 0.89 % | $ 296 M | ||
|
Leap Therapeutics
LPTX
|
-1 | - | 368.57 % | $ 41.9 M | ||
|
Lumos Pharma
LUMO
|
-0.791 | - | - | $ 35.3 M | ||
|
Gamida Cell Ltd.
GMDA
|
-5.85 | - | -18.25 % | $ 5.04 M | ||
|
Axcella Health
AXLA
|
-0.359 | - | -16.42 % | $ 249 M | ||
|
Metacrine
MTCR
|
-0.287 | - | - | $ 24.2 M | ||
|
Zealand Pharma A/S
ZEAL
|
-0.706 | - | 0.52 % | $ 821 M | ||
|
Myovant Sciences Ltd.
MYOV
|
3.78 | - | -0.04 % | $ 2.62 B | ||
|
Bellerophon Therapeutics
BLPH
|
-4.42 | - | -74.18 % | $ 955 K | ||
|
Idera Pharmaceuticals
IDRA
|
-0.0572 | - | -23.04 % | $ 26.6 M | ||
|
Akero Therapeutics
AKRO
|
-14.1 | - | - | $ 3.67 B | ||
|
Verona Pharma plc
VRNA
|
-359 | - | - | $ 69.7 B | ||
|
Atreca
BCEL
|
-0.607 | - | -11.76 % | $ 5.79 M | ||
|
Guardion Health Sciences
GHSI
|
-0.953 | - | -0.31 % | $ 3.64 M | ||
|
Opiant Pharmaceuticals
OPNT
|
60.5 | - | - | $ 109 M | ||
|
Akouos
AKUS
|
-2.88 | - | 0.23 % | $ 488 M | ||
|
ImmunoGen
IMGN
|
-4.43 | - | - | $ 7.92 B | ||
|
Vascular Biogenics Ltd.
VBLT
|
-0.0385 | - | -8.77 % | $ 12.4 M | ||
|
Cidara Therapeutics
CDTX
|
-0.84 | - | - | $ 1.41 B | ||
|
Iterum Therapeutics
ITRM
|
-1.04 | - | - | $ 591 K | ||
|
Virpax Pharmaceuticals
VRPX
|
-0.0509 | - | -45.12 % | $ 2.85 M | ||
|
Navidea Biopharmaceuticals
NAVB
|
-0.997 | - | -2.99 % | $ 2.47 M | ||
|
Stealth BioTherapeutics Corp
MITO
|
-10 | - | - | $ 23.9 M | ||
|
OncoSec Medical Incorporated
ONCS
|
-0.55 | - | 31.87 % | $ 1.61 M | ||
|
BioDelivery Sciences International
BDSI
|
7.5 | - | -4.8 % | $ 255 M | ||
|
Albireo Pharma
ALBO
|
-5.09 | - | -0.23 % | $ 916 M | ||
|
bluebird bio
BLUE
|
-0.0143 | - | - | $ 546 M | ||
|
Landos Biopharma
LABP
|
-2.35 | - | 0.58 % | $ 144 M | ||
|
CASI Pharmaceuticals
CASI
|
-4.26 | - | - | $ 35.4 M | ||
|
ContraFect Corporation
CFRX
|
-0.0235 | - | -5.16 % | $ 5.39 M | ||
|
Sigilon Therapeutics
SGTX
|
-0.774 | - | - | $ 728 M | ||
|
Regulus Therapeutics
RGLS
|
-1.97 | - | - | $ 155 M | ||
|
NGM Biopharmaceuticals
NGM
|
-0.961 | - | - | $ 127 M | ||
|
Aravive
ARAV
|
-0.928 | - | -13.39 % | $ 1.45 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
-0.982 | - | - | $ 231 M | ||
|
Crinetics Pharmaceuticals
CRNX
|
-10.9 | $ 84.95 | 0.13 % | $ 7.99 B |